Report of unscheduled material events or corporate changes - Form 8-K
Board of Directors
Frequently Asked Questions
Subscribe to Email Alerts
SEC Filing For null
AXIM BIOTECHNOLOGIES, INC. - 8-K (Filed: 05-04-2018)
Sub Document 1
SECURITIES AND EXCHANGE COMMISSION
Item 1.01 Entry into a Material Definitive Agreement
Sub Document 2
AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Througho
Corporate Contact Info
Copyright © 2018
. All rights reserved.
Market Data powered by QuoteMedia,
, SEC filings by Morningstar.